Supernus Pharmaceuticals' GAAP net income for 3 months of 2022 was $25.616 million, up 4.5 times from $5.694 million in the previous year. Revenue increased 16.5% to $152.506 million from $130.932 million a year earlier.
Supernus Pharmaceuticals' GAAP net income for 3 months of 2022 was $25.616 million, up 4.5 times from $5.694 million in the previous year. Revenue increased 16.5% to $152.506 million from $130.932 million a year earlier. 
ir.supernus.com
English (US) 